Cancer Cures Media ArticlesExcerpts of Key Cancer Cures Media Articles in Major Media
Below are key excerpts of revealing news articles on cancer cures from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
It was a small trial, just 18 rectal cancer patients, every one of whom took the same drug. But the results were astonishing. The cancer vanished in every single patient, undetectable by physical exam, endoscopy, PET scans or M.R.I. scans. Dr. Luis A. Diaz Jr. of Memorial Sloan Kettering Cancer Center, an author of a paper published Sunday in the New England Journal of Medicine describing the results ... said he knew of no other study in which a treatment completely obliterated a cancer in every patient. "I believe this is the first time this has happened in the history of cancer," Dr. Diaz said. Dr. Alan P. Venook, a colorectal cancer specialist at the University of California, San Francisco, who was not involved with the study, said he also thought this was a first. A complete remission in every single patient is "unheard-of," he said. These rectal cancer patients had faced grueling treatments – chemotherapy, radiation and, most likely, life-altering surgery that could result in bowel, urinary and sexual dysfunction. Some would need colostomy bags. They entered the study thinking that, when it was over, they would have to undergo those procedures because no one really expected their tumors to disappear. But they got a surprise: No further treatment was necessary. "There were a lot of happy tears," said Dr. Andrea Cercek, an oncologist at Memorial Sloan Kettering Cancer Center and a co-author of the paper. Another surprise, Dr. Venook added, was that none of the patients had clinically significant complications.
Note: Will this amazing treatment be suppressed, like so many others before it? Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Dr. Seema Doshi was shocked and terrified when she found a lump in her breast that was eventually confirmed to be cancerous. "That rocked my world," said Dr. Doshi, a dermatologist in private practice. "I thought, â€That's it. I will have to do chemotherapy.'" She was wrong. Dr. Doshi was the beneficiary of a quiet revolution in breast cancer treatment, a slow chipping away at the number of people for whom chemotherapy is recommended. Chemotherapy for decades was considered "the rule, the dogma," for treating breast cancer and other cancers, said Dr. Gabriel Hortobagyi, a breast cancer specialist. But data from a variety of sources offers some confirmation of what many oncologists say anecdotally – the method is on the wane for many cancer patients. Genetic tests can now reveal whether chemotherapy would be beneficial. For many there are better options with an ever-expanding array of drugs, including estrogen blockers and drugs that destroy cancers by attacking specific proteins on the surface of tumors. And there is a growing willingness among oncologists to scale back unhelpful treatments. The result spares thousands each year from the dreaded chemotherapy treatment, with its accompanying hair loss, nausea, fatigue, and potential to cause permanent damage to the heart and to nerves in the hands and feet. The diminution of chemotherapy treatment is happening for some other cancers, too, including lung cancer.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
Doctors have used ultrasound to successfully treat prostate cancer in a new study promising a new alternative to surgery. Prostate is the second most deadly type of cancer in men, with lung cancer the only variant to claim more lives. Treatment is challenging because surgery and radiation can leave men incontinent or impotent. However, a pioneering new technique avoids the risks by using a rod-shaped device inserted into the urethra while guided by magnetic resonance to administer precise bursts of ultrasound. The sound waves heat and destroy the tumour, leaving surrounding areas unharmed. The new study was presented at the annual meeting of the Radiological Society of North America and involved 115 men with localised prostate cancer. After treatment with ultrasound, clinically significant cancer was eliminated in 80 per cent of the group, with 65 per cent having no signs of cancer after one year. Most of the men also saw reduced blood-antigen markers for prostate cancer, and overall no bowel complications were reported. Study co-author Steven Raman, professor of radiology and urology at the University of California at Los Angeles, said: “It’s an outpatient procedure with minimal recovery time. “We saw very good results in the patients, with a dramatic reduction of over 90 per cent in prostate volume and low rates of impotence with almost no incontinence.” The process, called Tulsa-Pro, has been approved for clinical use in Europe.
Note: Why isn't this exciting new development approved or even reported in the US? And learn about a man who developed a similar treatment almost a century ago only to have it quashed by the medical establishment.
Scientists have created a new cowpox-style virus in a bid to cure cancer. The treatment, called CF33, can kill every type of cancer in a petrie dish and has shrunk tumours in mice, The Daily Telegraph reported. US cancer expert Professor Yuman Fong is engineering the treatment, which is being developed by Australia biotech company Imugene. They are hoping the treatment will be tested on breast cancer patients, among other cancer sufferers, next year. Professor Fong is currently in Australia to organise the clinical trials, which will also be run overseas. Patients with triple negative breast cancer, melanoma, lung cancer, bladder, gastric and bowel cancer would be tested in the 'basket study'. The virus, which causes the common cold, was turned into a treatment for brain cancer by scientists in the US. The cancer in some patients disappeared for years before it came back, while others saw tumours shrink considerably. Similarly, a form of the cold sore virus called Imlygic or T-Vec was found to be able to treat melanoma, as it helped the body's immune system recognise and destroy tumours and melanoma cells in the body. Cancer patients would have the engineered virus injected directly into their tumours for the breakthrough treatment. It's hoped the virus would infect the cancer calls and make them explode. The immune system is then expected to be alerted about other cancer cells in the body, prompting the diseased cells to be killed.
Note: For more along these lines, see concise summaries of deeply revealing news articles on promising cancer research from reliable major media sources.
[Jim] Anderson is standing in an unassuming patch of woodland in Crystal Falls, in Michigan's Upper Peninsula. He is revisiting an organism living under the forest floor that he and his colleagues discovered nearly 30 years ago. This is the home of Armillaria gallica, a type of honey mushroom. When Anderson and his colleagues visited Crystal Falls in the late 1980s, they discovered that what at first appeared to be a rich community of Armillaria gallica flourishing beneath the mulch of leaf litter and top soil of the forest floor was – in fact – one giant individual specimen. They estimated it covered an area about 91 acres, weighed 100 tonnes and was at least 1,500 years old. Analysis produced [a] surprising insight, one that could help us humans in our fight against ... cancer. The Canadian researchers discovered what may be the secret behind the Armillaria gallica's extraordinary size and age. It appears the fungus has an extremely low mutation rate – meaning it avoids potentially damaging alterations to its genetic code. As organisms grow, their cells divide into two to produce new daughter cells. Over time, the DNA in the cells can become damaged leading to errors, known as mutations, creeping into the genetic code. This is thought to be one of the key mechanisms that causes aging. But it seems the Armillaria gallica in Crystal Falls might have some inbuilt resistance to this DNA damage.
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
A small team of Israeli scientists is telling the world they will have the first “complete cure” for cancer within a year, The Jerusalem Post reported. And not only that, but they claim it will be brief, cheap and effective and will have no or minimal side-effects. “We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, chairman of the board of Accelerated Evolution Biotechnologies Ltd. (AEBi), a company founded in 2000 in ... Ness Ziona, Israel. A development-stage biopharmaceutical company engaged in discovery and development of therapeutic peptides, AEBi developed the SoAP platform, a combinatorial biology screening platform technology, which provides functional leads—agonist, antagonist, inhibitor, etc. - to very difficult targets. Called MuTaTo (multi-target toxin), researchers said the drug is essentially "on the scale of a cancer antibiotic a disruption technology of the highest order." Aridor told The Jerusalem Post: “Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.” Currently in development ... the potential game-changer in the world-wide fight against cancer will use a combination of cancer-targeting peptides and a toxin that will specifically kill cancer cells. Every sixth death in the world is due to cancer, making it the second leading cause of death, second only to cardiovascular disease.
Note: Yet even in this article the attacks on these scientists have already begun. The cancer industry does not want to lose literally billions of dollars in profits. For more on this, see the Royal Rife story. For more along these lines, see concise summaries of deeply revealing major media news articles on other cancer treatments with high promise which were suppressed.
You can protect yourself from cancer by eating organic. Those who frequently eat organic foods lowered their overall risk of developing cancer, a study published Monday in JAMA Internal Medicine finds. Specifically, those who primarily eat organic foods were more likely to ward off non-Hodgkin lymphoma and postmenopausal breast cancer compared to those who rarely or never ate organic foods. A team of researchers looked at the diets of 68,946 French adults. More than three-quarters of the volunteers were women, in their mid-40s on average. Comparing the participants' organic food scores with cancer cases, the researchers calculated a negative relationship between high scores (eating the most organic food) and overall cancer risk. Those who ate the most organic food were 25% less likely to develop cancer. Specifically, they were 73% less likely to develop non-Hodgkin lymphoma and 21% less likely to develop post-menopausal breast cancer. Even participants who ate low-to-medium quality diets yet stuck with organic food experienced a reduced risk of cancer, the authors found. The authors theorize a "possible explanation" for the negative relationship between organic food and cancer risk stems from the "significant" reduction of contamination that occurs when conventional foods are replaced by organic foods. The new findings are consistent with those of the International Agency for Research in Cancer, which found pesticides are cancer causing in humans
Note: For more along these lines, see concise summaries of deeply revealing news articles on food corruption from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
A vaccine injected into a tumor triggers the immune system to kill cancer, a new study in mice confirms. Stanford researchers have now begun seeking human patients who want to help test this approach. The research behind this potential new cancer treatment was published Wednesday in Science Translational Medicine. Cancer vaccines work a bit differently than a vaccine against the measles or the flu. Those shots are meant to train an immune system to target an infection before the virus or bacteria arrives. Cancer vaccines, however, are given after a person is diagnosed. This shot ... combines two components: a short piece of DNA molecules that can stimulate the immune system to create greater quantities of a receptor called OX40 and a protein that sticks to those receptors, prompting the immune cells to attack the tumor. [Study co-author Dr. Ronald Levy] and his colleagues tested their vaccine in more than 90 mice, some with a tumor transplanted into them and others that were genetically primed to develop cancer. However, the next step in this research will go well beyond mice. Levy and his colleagues have begun looking for about 15 people with lymphoma to test the vaccine in a clinical trial. If the trials are successful, he believes it could help people with a wide variety of cancers. “I don’t think there’s a limit to the type of tumor we could potentially treat, as long as it has been infiltrated by the immune system,” he stated.
High doses of vitamin C injected into the blood stream could prove effective in treating cancer, according to new research. Scientists said vitamin C infusions, which were up to 1,000 times higher than recommended intake levels, selectively targeted tumour cells in cancer patients. This increased the rates of cell deaths and sensitised them to radiation and chemotherapy. The treatment also appeared to be safe, producing mild side effects such as frequent bathroom trips and a dry mouth. Eleven brain cancer patients were given three infusions of vitamin C a week for two months followed by a further two per week for seven months while receiving standard radiotherapy and chemotherapy. Tests showed that iron in their tumours reacted with the vitamin to form highly reactive and destructive “free radical” hydrogen peroxide molecules. The free radicals were thought to cause selective DNA damage in cancerous, but not healthy, cells. This in turn was expected to lead to enhanced cancer cell death as well as sensitisation to radiation and chemotherapy drugs. US researcher Dr Garry Buettner, from the University of Iowa, said: “This paper reveals a metabolic frailty in cancer cells that is based on their own production of oxidizing agents that allows us to utilise existing redox active compounds, like vitamin C, to sensitise cancer cells to radiation and chemotherapy.” The safety study sets the stage for larger Phase II trials investigating whether high-dose vitamin C injections can extend the lifespan of cancer patients.
Dr. Hadiyah-Nicole Green is one of fewer than 100 black female physicists in the country, and the recent winner of $1.1 million grant to further develop a technology she’s pioneered that uses laser-activated nanoparticles to treat cancer. Green, who lost her parents young, was raised by her aunt and uncle. While still at school, her aunt died from cancer, and three months later her uncle was diagnosed with cancer, too. Green went on to earn her degree in physics at Alabama A&M University, being crowned Homecoming Queen while she was at it, before going on full scholarship to University of Alabama in Birmingham to earn her Masters and Ph.D. There Green would become the first to work out how to deliver nanoparticles into cancer cells exclusively, so that a laser could be used to remove them, and then successfully carry out her treatment on living animals. As she takes on her growing responsibilities, Green still makes time to speak at schools, Boys & Girls Clubs and other youth events. “Young black girls don’t see those role models (scientists) as often as they see Beyonce or Nicki Minaj,” says Green. “It’s important to know that our brains are capable of more.”
Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
As a physician, I have encountered many people who believe that heart disease, which is the single biggest cause of death among Americans, is largely controllable. After all, if people ate better, were physically active and stopped smoking, then lots of them would get better. This ignores the fact that people can’t change many risk factors of heart disease like age, race and family genetics. People don’t often seem to feel the same way about cancer. They think it’s out of their control. A ... recent study published in Nature argues that there is a lot we can do. Many studies have shown that environmental risk factors and exposures contribute greatly to many cancers. Diet is related to colorectal cancer. Alcohol and tobacco are related to esophageal cancer. HPV is related to cervical cancer, and hepatitis C is related to liver cancer. And you’d have to be living under a rock not to know that smoking causes lung cancer and that too much sun can lead to skin cancer. Using sophisticated modeling techniques, the researchers argued that less than 30 percent of the lifetime risk of getting many common cancers was because of intrinsic risk factors, or the “bad luck.” The rest were things you can change. [More] recently, in JAMA Oncology, researchers sought to quantify how a healthful lifestyle might actually alter the risk of cancer. They [found that] about 25 percent of cancer in women and 33 percent in men was potentially preventable.
The phrase “cancer screening saves lives” is ... familiar to most consumers of public service announcements. But that advice may be misleading. The ubiquitous adage ... fails to take into account deaths linked to factors related to the screening itself. For example, prostate cancer screening is known to return “numerous” false positives, writes Vinay Prasad, an assistant professor at Oregon Health and Science University, and contributes to over 1 million prostate biopsies a year. The procedure is “associated with serious harms, including admission to hospital and death.” What’s more, men diagnosed with prostate cancer are “more likely to have a heart attack or commit suicide in the year after diagnosis,” he writes. A similar case can be made for breast cancer screening. Fully 60 percent of women who get regular mammograms for 10 years have been handed a false positive result at some point. Being told you have breast cancer - even if it turns out that the test result was incorrect - has been associated with “psychosocial distress as great as a breast cancer diagnosis.” A massive study of 90,000 women over 25 years found that the regular screening did not change the women’s death rates. In fact, if anything, the screenings harmed some women: Out of every five cancers detected with the technology and treated, one was “not a threat to the woman’s health and did not need treatment such as chemotherapy, surgery or radiation,” all of which can cause serious side effects.
Note: Read more about routine over-diagnosis and unnecessary treatment of cancer in this New York Times article. And learn about the promising cancer research that has been largely suppressed by the medical-industrial complex. For more, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.
His body ravaged by chemotherapy treatments, retired radio engineer John Kanzius spent months in his basement in 2003 cobbling together a makeshift tumor-killing machine. Kanzius had no medical background. He had been a ham radio operator and the owner of a television and radio station company. But he had leukemia, and he did not want to die. He did not know it then, but the John Kanzius's Noninvasive Radiowave Cancer Device ... would eventually make the pages of respected medical journals and attract the support of leading cancer researchers. Dr. Steven A. Curley, an oncologist ... launched Kanzius’s research into the national spotlight and devoted his career to the project. Curley had treated many cancer patients, but [grew] particularly close with Kanzius. In 2009, Kanzius died at 64 from pneumonia while undergoing chemotherapy. Many thought the Kanzius machine would die with him. But this May, Curley filed protocols with the Italian Ministry of Health to test the radio wave machine on humans diagnosed with pancreatic and liver cancer. Researchers from the University of Pittsburgh, the MD Anderson Cancer Center and Rice University tested the technology [on] human cancer cells in petri dishes, as well as into tumors in mice, rats, rabbits and pigs. Using the Kanzius machine, they were able to heat [injected] nanoparticles and, as a result, kill all those cancerous cells [while surrounding healthy areas remained intact]. Results were published in the oncology medical journal Cancer, as well as Nano Research.
Note: Learn more about promising cancer treatments that are emerging and why these are frequently overlooked. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.
In late 2012, Brice Royer was lying on a bed in terrible pain, thinking about how to kill himself. Today, the pain is still there and the malignant tumour in his stomach is no smaller. But he has never been happier. A year ago, Royer, 31, decided to give and receive freely without the use of money in an effort to build community. Thinking he was staring down a death sentence, Royer [researched] and reflect on the causes of illness. Toxins in the environment. Loneliness. Stress. “The root cause (is) a lack of love in our society,” Royer says. “A lot of the problems that we have today - anything from the housing crisis in Vancouver, how expensive things are, to working at a stressful job, making ends meet and not having much time to have community or friends - all these things I feel led to a lot of health problems and in my case, can aggravate cancer.” Royer researched where the healthiest people in the world live and the lifestyle they practise. “They all take care of each other. They all have big families and small communities and they all have something called the gift economy. They are isolated from the market economy,” Royer explains. [He] suggested to a friend that they practise this within their own circle using a Facebook group. True to philosophy, he offered to pay someone else’s rent ... for a year instead of his own. The woman he helped was a chronically ill single mother. The biggest payoff, he says, is the community he’s built and the love and support he gets from friends.
In a new study, researchers found that breast-cancer patients who had high levels of vitamin D were twice as likely to survive [as] women with low levels. They reviewed five studies that observed more than 4,440 women. "The study has implications for including vitamin D as an adjuvant to conventional breast cancer therapy," study co-author Dr. Heather Hofflich, an associate professor of medicine at the University of California San Diego, said in a press release. The researchers recommend that vitamin D should be added to the various treatments given to women fighting breast cancer. The body naturally produces vitamin D when exposed to sunlight, but milk, fatty fish and other foods can also boost production. Patients could also take vitamin D supplements.
Note: This is huge news! Why isn't this exciting development getting more press coverage? Read numerous major media articles revealing potential cancer cures which have received little attention. And see an informative article with more on the Vitamin D connection.
High-dose vitamin C can boost the cancer-killing effect of chemotherapy in the lab and mice, research suggests. Given by injection, it could potentially be a safe, effective and low-cost treatment for ovarian and other cancers. US scientists ... call for large-scale government clinical trials. Vitamin C has long been used as an alternative therapy for cancer. In the 1970s, chemist Linus Pauling reported that vitamin C given intravenously was effective in treating cancer. However, clinical trials of vitamin C given by mouth failed to replicate the effect, and research was abandoned. It is now known that the human body quickly excretes vitamin C when it is taken by mouth. However, scientists at the University of Kansas say that when given by injection vitamin C is absorbed into the body, and can kill cancer cells without harming normal ones. The researchers injected vitamin C into human ovarian cancer cells in the lab, into mice, and into patients with advanced ovarian cancer. They found ovarian cancer cells were sensitive to vitamin C treatment, but normal cells were unharmed. The treatment worked in tandem with standard chemotherapy drugs to slow tumour growth. "Because vitamin C has no patent potential, its development will not be supported by pharmaceutical companies," said lead researcher Qi Chen. "We believe that the time has arrived for research agencies to vigorously support thoughtful and meticulous clinical trials with intravenous vitamin C."
Note: Read more about this amazing cancer research. For more along these lines, see concise summaries of deeply revealing news articles on promising cancer research that has been suppressed by the medical industry.
Bees may soon be able to take some of the sting out of cancer by detecting it early and getting patients into treatment sooner. Honeybees are known for their exquisitely sensitive sense of smell. They don't have noses, but their feet, tongues and antennae are packed with olfactory glands. They can also be quickly trained to do their "waggle dance" when they associate a specific smell with a food source. Taking advantage of these facts, Portuguese scientist Susana Soares has invented a two-chambered glass dome that uses bees to snuff out cancer. "The glass objects have two enclosures: a smaller chamber that serves as the diagnostic space and a bigger chamber where previously trained bees are kept for the short period of time necessary for them to detect general health," Soares wrote on her website. "People exhale into the smaller chamber, and the bees rush into it if they detect on the breath the odor that they were trained to target." Soares said she could train bees in 10 minutes to identify cancer and other diseases, such as tuberculosis and diabetes in their early stages. By exposing the insects to the odor molecules produced by an illness and then feeding them sugar, they learn to associate the smell with a food reward. Soares said that her bee chamber was an inexpensive, sustainable and highly accurate diagnostic tool. And, she points out, bees, as well as wasps, are already used regularly to sniff out land mines and illegal drugs.
A group of experts advising the nation’s premier cancer research institution has recommended changing the definition of cancer and eliminating the word from some common diagnoses as part of sweeping changes in the nation’s approach to cancer detection and treatment. The recommendations, from a working group of the National Cancer Institute, were published [in] The Journal of the American Medical Association. They say, for instance, that some premalignant conditions, like one that affects the breast called ductal carcinoma in situ, which many doctors agree is not cancer, should be renamed to exclude the word carcinoma so that patients are less frightened and less likely to seek what may be unneeded and potentially harmful treatments that can include the surgical removal of the breast. The group, which includes some of the top scientists in cancer research, also suggested that many lesions detected during breast, prostate, thyroid, lung and other cancer screenings should not be called cancer at all but should instead be reclassified as IDLE conditions, which stands for “indolent lesions of epithelial origin.” The impetus behind the call for change is a growing concern among doctors, scientists and patient advocates that hundreds of thousands of men and women are undergoing needless and sometimes disfiguring and harmful treatments for premalignant and cancerous lesions that are so slow growing they are unlikely to ever cause harm. Once doctors and patients are aware a lesion exists, they typically feel compelled to biopsy, treat and remove it, often at great physical and psychological pain and risk to the patient.
Note: Isn't it interesting that a diagnosis which might not even be accurate can so change a person's life? For more on promising cancer cures which are being suppressed by the medical-industrial complex, see the deeply revealing reports from reliable major media sources available here.
The use of aspirin and other nonsteroidal anti-inflammatory drugs significantly reduces the risk for cancer, but no one has been able to explain why. Now researchers have found that these drugs slow the accumulation of a type of DNA change called somatic genome abnormalities, or SGAs, that lead to uncontrolled cell growth. The researchers tracked SGAs with periodic biopsies over an average of almost 12 years. Over all, the use of nonsteroidal anti-inflammatory drugs was associated with a 90 percent reduction in the rate of mutations. “We used techniques used to measure mutation rate in viruses like H.I.V. to measure it in humans,” said the senior author, Carlo C. Maley, director of the Center for Evolution and Cancer at the University of California, San Francisco. “We measured whole pieces of chromosomes that are getting deleted or copied.” Apparently aspirin slows that rate of mutation. The study, published last month in the journal PLoS Genetics, is very small, Dr. Maley said, and has yet to be reproduced in a larger population. But since most cancers take decades to develop, he added, “if you could just slow it down, you could slow it enough to have people die of something else.”
Note: For more on potential cancer cures, see the deeply revealing reports from reliable major media sources available here.
Sixteen-year-old Jack Andraka's innovative mind led him to create a new way to detect pancreatic, ovarian and lung cancer. "I created a new way to detect pancreatic, ovarian and lung cancer that costs three cents and takes five minutes to run," he said. After a close friend died from pancreatic cancer, this 16-year-old from Crownsville, Maryland, unleashed his hyper-drive intellect on preventing more cancer deaths. "It's 168 times faster, over 26,000 times less expensive, and over 400 times more sensitive than our current methods of diagnosis," he said. Tinkering in his room and using information readily available online, he came up with a new way to detect cancer. "85 percent of all pancreatic cancers are diagnosed late, when someone has less than a two percent chance of survival. And our current test costs $800 per test and misses 30 percent of all pancreatic cancers," he said. He won last year's Intel International Science and Engineering Fair. The sweet validation came with $100,000 in scholarships, but Jack Andraka's got his eye on even bigger things. "The name of the competition is called the Tricorder XPRIZE," he said. "It's a $10 million prize. Essentially what you have to do is develop something the size of a smartphone that you scan over your skin and it will diagnose any disease instantly." Jack is fielding a team of other high-schoolers to compete against 300 teams of adult scientists and corporations in the Qualcomm Tricorder XPRIZE competition. He says youth is an advantage -- that new eyes are more likely to solve old problems.
Note: Let's hope this invention gets fast tracked and makes it to market. Notice how little attention this exciting development received. To read about many potential cancer cures reported in major media which have not made it to market for financial reasons, click here. For a treasure trove of great news articles which will inspire you to make a difference, click here.
Researchers say they have created a drug that has killed every kind of cancer tumor it has come in contact with, according to Science Magazine. The antibody treatment works by blocking a protein called CD47 which tricks the body into not destroying cancerous cells. After the protein is blocked, the body can then recognize the cancer cells as invaders and attack. While the research is seen as a step closer to discovering a treatment that can cure all cancers, the drug has only been tested on mice and will need to prove itself on humans before it can be available to patients. This may take a few years. The research team has been given the green light and recently received a four-year, $20 million grant to conduct human clinical trials. Research for this new drug started a decade ago when biologist Irving Weissman at Stanford University was studying leukemia cells. He found that that leukemia cells produce higher levels of the CD47 protein than healthy cells. CD47 acts as a "don't-eat-me" signal, instructing the body to not eat harmful cells. Cancers take advantage of this signal to trick the immune system into ignoring them. Weissman's research showed that blocking CD47 can cure more than just blood cancers. The drug can also shrink or cure human breast, ovary, colon, bladder, brain, liver and prostate tumors that have been transplanted into mice. The treatment forced the mice's immune system to kill the cancer cells. This means this single drug could cure a variety of cancers and prevent cancers from spreading in the body.
Note: With many millions around the world dying of cancer every year, why aren't the most promising treatments being fast-tracked? Why is this article titled a "rumor"? Why isn't this making major headlines? Why isn't the very promising treatment of DCA, which is both cheap and incredibly promising, being given many millions to move rapidly forward? To read major media articles describing other potential cures not being adequately funded, click here. To understand why some treatments are suppressed, click here.
Cambridge University scientists say they have seen four-stranded DNA at work in human cells for the first time. The famous "molecule of life", which carries our genetic code, is more familiar to us as a double helix. But researchers tell the journal Nature Chemistry that the "quadruple helix" is also present in our cells, and in ways that might possibly relate to cancer. They suggest that control of the structures could provide novel ways to fight the disease. "The existence of these structures may be loaded when the cell has a certain genotype or a certain dysfunctional state," said Prof Shankar Balasubramanian from Cambridge's department of chemistry. Balasubramanian's group has been pursuing a four-stranded version of the molecule that scientists have produced in the test tube now for a number of years. The new research is said to be the first to firmly pinpoint the quadruple helix in human cells.
Note: For deeply revealing reports from reliable major media sources on promising new cancer treatments, any of which have been suppressed, click here.
A report released this month by the Centers for Disease Control and Prevention and three prominent cancer research groups shows that cancer deaths in the United States are declining for men, women and children. New cancer diagnoses also declined for men from 2000 through 2009, the period the report examines, but remained stable for women and increased slightly for children. Here are the numbers: 1.8%: The percentage that cancer deaths decreased for both men and children from 2000 through 2009. For women, the decrease was 1.4 percent. 10%: The percentage that death rates decreased in the most common cancers in men. 15: The number of cancers most common in women that showed decreased death rates.
Note: For deeply revealing reports from reliable major media sources on promising cancer treatments and trends, click here.
Marijuana, already shown to reduce pain and nausea in cancer patients, may be promising as a cancer-fighting agent against some of the most aggressive forms of the disease. A growing body of early research shows a compound found in marijuana - one that does not produce the plant's psychotropic high - seems to have the ability to "turn off" the activity of a gene responsible for metastasis in breast and other types of cancers. Two scientists at San Francisco's California Pacific Medical Center Research Institute first released data five years ago that showed how this compound - called cannabidiol - reduced the aggressiveness of human breast cancer cells in the lab. "The preclinical trial data is very strong, and there's no toxicity. There's really a lot of research to move ahead with and to get people excited," said Sean McAllister, who along with scientist Pierre Desprez, has been studying the active molecules in marijuana - called cannabinoids - as potent inhibitors of metastatic disease for the past decade. Martin Lee, director of Project CBD, [a] group that works to raise awareness of the scientific promise of the compound, described the cannabidiol research as potent both as a medicine and a myth buster. "It debunks the idea that medicinal marijuana is really about people wanting to get stoned," said Lee, author of Smoke Signals, a book published last month about the medical and social history of marijuana. "Why do they want it when it doesn't even get them high?"
Note: For an educational, 45-minute documentary on this topic titled "What if Cannabis Cured Cancer?," click here. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply inspiring reports from reliable sources, click here.
Mounting evidence shows ‘cannabinoids’ in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Peer-reviewed studies in several countries ... show that THC and other marijuana-derived compounds, known as “cannabinoids,” are effective not only for cancer-symptom management (nausea, pain, loss of appetite, fatigue), they also confer a direct antitumoral effect. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. THC treatment was associated with significantly reduced tumor cell proliferation in every test subject. Harvard University scientists reported that THC slows tumor growth in common lung cancer and “significantly reduces the ability of the cancer to spread.” What’s more ... THC selectively targets and destroys tumor cells while leaving healthy cells unscathed. Conventional chemotherapy drugs, by contrast, are highly toxic; they indiscriminately damage the brain and body. There is mounting evidence ... that cannabinoids “represent a new class of anticancer drugs that retard cancer growth, inhibit angiogenesis [the formation of new blood cells that feed a tumor] and the metastatic spreading of cancer cells.” Within the medical science community, the discovery that cannabinoids have anti-tumoral properties is increasingly recognized as a seminal advancement in cancer therapeutics.
Note: Yet treatment with cannabinoids continues to be largely illegal in the US. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply revealing reports from reliable major media sources on promising cancer-cure research, click here.
A single treatment to cure all cancers? Scientists may be one step closer. In a recent study, scientists reported that they successfully tested an antibody treatment that shrank human breast, ovary, colon, bladder, brain, liver and prostate tumors transplanted into mice. The antibody blocks a protein called CD47, which normally sits on the cell surface and issues a “don’t eat me” signal that prevents the body’s immune system from attacking it. About a decade ago, scientists at Stanford University School of Medicine, led by professor of pathology Irving Weissman, discovered that using an antibody to block CD47 cured some cases of leukemia and lymphoma in mice by allowing macrophages to seek and destroy the cancerous cells. In the new study, Weissman’s Stanford team showed that the CD47-blocking antibodies may also work against a number of other cancers. The researchers found that CD47 existed on nearly every cell, which suggests that the protein may be common to all cancers. Cancer cells expressed about three times more CD47 than healthy cells. “If the tumor was highly aggressive, the antibody also blocked metastasis. It’s becoming very clear that, in order for a cancer to survive in the body, it has to find some way to evade the cells of the innate immune system,” said Weissman in a statement. The antibody treatment didn’t work in all cases. Some mice injected with breast cancer cells from a human patient showed no changes after treatment. Yet in five mice with breast cancer, the antibody treatment cured them, with no signs of recurrence four months after treatment.
Note: With millions around the world dying of cancer every year, why aren't the most promising treatments being fast tracked? Why did it take 10 years form Weissman to reach this stage? Why isn't the very promising treatment of DCA, which is both cheap and incredibly promising, being given many millions to move rapidly forward? To read major media articles describing other potential cures not being adequately funded, click here. To understand why some treatments are suppressed, click here.
A few years ago researchers in California received widespread attention for showing that dogs can smell cancer on a human’s breath. With 99 percent accuracy the canines could detect if a person had lung or breast cancer, beating the best figures from standard laboratory tests. Subsequent studies confirmed the results. Technology startups have hustled to build digital devices that can mimic the dogs’ olfactory sense and reduce the need for biopsies and CAT scans. Metabolomx, a 12-person outfit in Mountain View, Calif., [is] bringing a cancer-sniffing device to market. The machine analyzes the breath and its volatile organic compounds, or VOCs—aerosolized molecules that, among other things, determine how something smells. Tumors produce their own VOCs, which pass into the bloodstream. The lungs create a bridge between the bloodstream and airways, so the breath exhaled by a patient will carry the VOC signatures of a tumor if one is present. “It may seem surprising, but it’s actually very straightforward,” says Paul Rhodes, the co-founder and chief executive officer at Metabolomx. Dr. Peter Mazzone, a lung cancer expert at the Cleveland Clinic, recently published results from a trial he ran with an early version of the Metabolomx machine. He studied 229 people and found that the machine could detect lung cancer more than 80 percent of the time. Just as intriguing, the machine outdid the dogs by distinguishing between different forms of lung cancer with about 85 percent accuracy, giving the doctor insight into whether a patient had an aggressive case.
Note: A machine has 80% accuracy in detecting this lethal disease, while sniffing dogs have 99% accuracy. Which would you rather have? For lots more from reliable sources on promising potential cancer-cure breakthroughs, click here.
Born to Chinese immigrants, 17-year-old Angela Zhang of Cupertino, California is a typical American teenager. She's really into shoes and is just learning how to drive. But there is one thing that separates her from every other student at Monta Vista High School, something she first shared with her chemistry teacher, Kavita Gupta. It's a research paper Angela wrote in her spare time -- and it is advanced, to say the least. "Cure for cancer -- a high school student," said Gupta. "It's just so mind-boggling. I just cannot even begin to comprehend how she even thought about it or did this." When she was a freshman, she started reading doctorate level papers on bio-engineering. By sophomore year she'd talked her way into the lab at Stanford, and by junior year was doing her own research. Angela's idea was to mix cancer medicine in a polymer that would attach to nanoparticles -- nanoparticles that would then attach to cancer cells and show up on an MRI, so doctors could see exactly where the tumors are. Then she thought [of aiming] an infrared light at the tumors to melt the polymer and release the medicine, thus killing the cancer cells while leaving healthy cells completely unharmed. It'll take years to know if it works in humans -- but in mice -- the tumors almost completely disappeared. Angela recently entered her project in the national Siemens science contest. It was no contest. She got a check for $100,000.
Note: If this technique has already melted tumors in mice, why is CBS saying it will take years to know if it works in humans? Why wouldn't millions be poured in to fast track research on this exciting technology?
From the island nation known for the quality of its cigars comes some pretty big news today: Cuban medical authorities have released the first therapeutic vaccine for lung cancer. CimaVax-EGF is the result of a 25-year research project at Havana’s Center for Molecular Immunology, and it could make a life or death difference for those facing late-stage lung cancers. CimaVax-EGF isn’t a vaccine in the preventative sense--that is, it doesn’t prevent lung cancer from taking hold in new patients. It’s based on a protein related to uncontrolled cell proliferation--that is, it doesn’t prevent cancer from existing in the first place but attacks the mechanism by which it does harm. As such it can turn aggressive later-stage lung cancer into a manageable chronic disease by creating antibodies that do battle with the proteins that cause uncontrolled cell proliferation, researchers say. Chemotherapy and radiotherapy are still recommended as a primary means of destroying cancerous tissue, but for those showing no improvement the new vaccine could be a literal lifesaver. The vaccine has already been tested in 1,000 patients in Cuba and is being distributed at hospitals there free of charge. That’s a big deal for a country where smoking is part of the national culture and a leading cause of death. If it proves as successful as researchers say it is, it should give those suffering from lung cancer reason to celebrate--just not with a Cohiba.
Note: For lots more on important health issues from reliable sources, click here.
An engineered virus, injected into the blood, can selectively target cancer cells throughout the body in what researchers have labelled a medical first. The virus attacked only tumours, leaving the healthy tissue alone, in a small trial on 23 patients, according to the journal Nature. Researchers said the findings could one day "truly transform" therapies. Cancer specialists said using viruses showed "real promise". Using viruses to attack cancers is not a new concept, but they have needed to be injected directly into tumours in order to evade the immune system. The virus, named JX-594 ... was injected at different doses into the blood of 23 patients with cancers which had spread to multiple organs in the body. Prof John Bell, lead researcher and from the University of Ottawa, said: "We are very excited because this is the first time in medical history that a viral therapy has been shown to consistently and selectively replicate in cancer tissue after intravenous infusion in humans. Intravenous delivery is crucial for cancer treatment because it allows us to target tumours throughout the body as opposed to just those that we can directly inject."
Note: With millions of people dying of cancer every year, why isn't this being fast tracked like the AIDS drugs were? For exciting information from reliable sources on promising new cancer cure possibilities, click here.
Doctors have treated only three leukemia patients, but the sensational results from a single shot could be one of the most significant advances in cancer research in decades. Doctors at the University of Pennsylvania say the treatment made the most common type of leukemia completely disappear in two of the patients and reduced it by 70 percent in the third. In each of the patients as much as five pounds of cancerous tissue completely melted away in a few weeks, and a year later it is still gone. The results of the preliminary test “exceeded our wildest expectations,” says immunologist Dr. Carl June a member of the Abramson Cancer Center's research team. Chemotherapy and radiation can hold this form of leukemia at bay for years, but until now the only cure has been a bone marrow transplant. A bone marrow transplant requires a suitable match, works only about half the time, and often brings on severe, life-threatening side effects such as pain and infection. So why has this remarkable treatment been tried so far on only three patients? Both the National Cancer Institute and several pharmaceutical companies declined to pay for the research. Neither applicants nor funders discuss the reasons an application is turned down.
Note: For key reports from reliable sources on hopeful new cancer treatments, click here.
Cancer is not one disease. It is many. Yet oncologists have long used the same blunt weapons to fight different types of cancer: cut the tumour out, zap it with radiation or blast it with chemotherapy that kills good cells as well as bad ones. New cancer drugs are changing this. Scientists are now attacking specific mutations that drive specific forms of cancer. A breakthrough came more than a decade ago when Genentech, a Californian biotech firm, launched a drug that attacks breast-cancer cells with too much of a certain protein, HER2. In 2001 Novartis, a Swiss drugmaker, won approval for Gleevec, which treats chronic myeloid leukaemia by attacking another abnormal protein. Other drugs take different tacks. Avastin, introduced in America in 2004 by Genentech, starves tumours by striking the blood vessels that feed them. These new drugs sell well. Last year Gleevec grossed $4.3 billion. Roche’s Herceptin (the HER2 drug) and Avastin did even better: $6 billion and $7.4 billion respectively. The snag, from society’s point of view, is that all these drugs are horribly expensive. Last year biotech drugs accounted for 70% of the increase in pharmaceutical costs in America, according to Medco, a drug-plan manager. Cancer plays a huge role in raising costs.
To call what the Hyde family has been through a "parent's worst nightmare" sounds like a horrible cliche. But, it's hard to imagine what else you could call it. Their two-year-old son Cash was diagnosed last year with a stage 4 brain tumor; he nearly died more times than they can count. He was miserable from the chemotherapy coursing through his body until his dad made a controversial decision to give cannabis to his young son. The doctors had no answers, so Mike found his own. It was relief for Cashy in the form of cannabis oil. It's illegal to possess without authorization from a medical professional. It's something doctors wouldn't even discuss. Mike got authorization to give Cashy the oil and, without telling them why, told the doctors to wean Cashy off the anti-nausea cocktail. Inserted through Cashy's feeding tube, a tiny amount of oil replaced all those drugs. The result, Mike said, was almost immediate. Mike Hyde, though, doesn't care about the controversy or the political battle over this drug. He cares that his son survived and is convinced not only did the cannabis help Cashy feel better, it prevented long-term damage to his organs. For Mike, the proof is in his vibrant two-year old boy. "It's very controversial, it's very scary. But, there's nothing more scary than losing your child." A few weeks ago, Cashy was back in Salt Lake City for scans and found out he's cancer-free.
By now, you likely know David Seidler, who won an Oscar on Sunday for best original screenplay for "The King's Speech," was a stutterer just like King George VI, whose battle with the speech disorder is portrayed in the film. What you might not know is that Seidler, 73, suffered from cancer, just like the king did. But unlike his majesty, Seidler survived the cancer, and he says he did so because he used the same vivid imagination he employed to write his award-winning script. Seidler says he visualized his cancer away. "I know it sounds awfully Southern California and woo-woo," he admits when he describes the visualization techniques he used when his bladder cancer was diagnosed nearly six years ago. "But that's what happened." Seidler says when he found out his cancer had returned, he visualized a "lovely, clean healthy bladder" for two weeks, and the cancer disappeared. He's been cancer-free for more than five years. Whether you can imagine away cancer, or any other disease, has been hotly debated for years. One camp of doctors will tell you that they've seen patients do it, and that a whole host of studies supports the mind-body connection. Other doctors, just as well-respected, will tell you the notion is preposterous, and there's not a single study to prove it really works. Seidler isn't concerned about studies. He says all he knows is that for him, visualization worked.
Note: The article goes on to quote a couple doctors who explain how chemically hope and visualization can cause the changes in the body's chemistry which could lead to spontaneous remission in cancer. For other fascinating major media articles listing potential cancer cures, click here.
Is the common nature of cancer worldwide purely a man-made phenomenon? That is what some researchers now suggest. Scientists have only found one case of the disease in investigations of hundreds of Egyptian mummies, researcher Rosalie David at the University of Manchester in England said in a statement. The rarity of cancer in mummies suggests it was scarce in antiquity, and "that cancer-causing factors are limited to societies affected by modern industrialization," researcher Michael Zimmerman at Villanova University in Pennsylvania said in a statement. "In an ancient society lacking surgical intervention, evidence of cancer should remain in all cases." Zimmerman was the first to diagnose cancer in an Egyptian mummy by analyzing its tissues on a microscopic level, identifying rectal cancer in an unnamed mummy who had lived in the Dakhleh Oasis during the Ptolemaic period 1,600 to 1,800 years ago. As they analyzed ancient literature, they did not find descriptions of operations for breast and other cancers until the 17th century, and the first reports in the scientific literature of distinctive tumors have only occurred in the past 200 years, such as scrotal cancer in chimney sweepers in 1775, nasal cancer in snuff users in 1761 and Hodgkin's disease in 1832. David and Zimmerman therefore argue that cancer nowadays is largely caused by man-made environmental factors such as pollution and diet. They detailed their findings in the October issue of the journal Nature Reviews Cancer.
Note: For key reports from reliable sources on important health issues, click here.
UC Davis just announced a seminar for the public on "men's health." That title notwithstanding, the program appears to be entirely about prostate cancer and in particular about the prostate specific antigen screening test. Many possible screening programs turn out not to do any good - and in fact some tests like PSA cause harm. That's why virtually all expert public health panels do not recommend the PSA test. A blood test that isn't accurate can fail to find disease that's present, leading to false reassurance. It can also report disease when it's not really there, leading to unnecessary use of other tests (like biopsy) that are not so benign. Perhaps most concerning, the PSA test frequently identifies something that qualifies as cancer under a microscope but acts nothing like cancer in real life. That is to say, the large majority of PSA-discovered "cancers" would never cause any problem whatsoever if they went undetected. Finding something through screening invariably leads to treating it. Most of the men so treated would have been just fine if they never knew about the cancer. But when they're treated ... the majority suffer really life-affecting effects, such as impotence and/or incontinence. That's why both of the two very large trials of PSA screening published in 2009 found no (or at most a tiny) benefit, but a great deal of harm.
Note: This article was written by Michael Wilkes, a professor of medicine at UC Davis, and Jerome Hoffman, a professor of emergency medicine at the University of Southern California. Both are researchers/consultants for the U.S. Centers for Disease Control and Prevention.
The psychedelic drug psilocybin, the active ingredient in "magic mushrooms," can improve mood and reduce anxiety and depression in terminal cancer patients, Los Angeles researchers reported [on September 6]. A single modest dose of the hallucinogen ... can improve patients' functioning for as long as six months, allowing them to spend their last days with more peace, researchers said. Dr. Charles Grob, a psychiatrist at Harbor- UCLA Medical Center and the Los Angeles Biomedical Research Institute ... and his colleagues studied 12 patients, ages 36 to 58, with advanced-stage cancer and anxiety resulting from their diagnoses. The patients were given a relatively low dose of psilocybin, 0.2 milligram per kilogram of body weight. Nonetheless, the team reported in the Archives of General Psychiatry, all patients reported a significant improvement in mood for at least two weeks after the psilocybin treatment and up to a six-month improvement on a scale that measures depression and anxiety. Most also reported a decreased need for narcotic pain relievers. No adverse reactions were observed. These types of patients normally do not respond well to psychological therapy, Grob said, but his study showed that the drug has "great promise for alleviating anxiety and other psychiatric symptoms."
Note: For many hope-inspiring reports from reliable sources on new cancer coping strategies and possible cures, click here.
Eric Merola's "Burzynski" charts how a Texas medical doctor and biochemist developed Antineoplastons, genetic-targeted medicines, and with them began to treat a wide range of cancers, including difficult-to-treat brain malignancies, with remarkable and continuing success only to bring down the full force of the medical establishment, which has laid assault to him in the most stupefying, devious and costly manner. Stanislaw Burzynski, a Polish immigrant ... eventually won a 14-year struggle – during which he found himself threatened with life imprisonment and astronomical fines for fraud and other violations – to obtain FDA-approved clinical trials of his Antineoplastons, an ordeal that cost Burzynski $2.2 million in legal expenses and the FDA $60 million in taxpayers' money. The film makes the case that big pharmacy holds the FDA in its thrall. Burzynski's Antineoplastons, with their high success rate and lack of side effects, pose a significant threat to the trillion-dollar industry of treating cancer with the traditional methods of surgery, radiation and chemotherapy.
Note: The Los Angeles Times now requires payment to view this article at this link. For the Burzynski clinic website, click here. You can watch part or all of this revealing movie at this link. For another powerful documentary featuring a variety of potential cancer cures that have been suppressed, click here. For excerpts from numerous major media articles with potential cancer cures that are being suppressed, click here.
Cancer patients reeling from metastasis may be on the verge of a major victory. Researchers at Weill Cornell Medical College say new anti-cancer agents may stop metastasis -- or the migration of cancer cells from a tumor to other parts of the body -- dead in its tracks. “More than 90 percent of cancer patients die from tumors spreading,” Dr. Xin-Yun Huang, a professor in the Department of Physiology and Biophysics at Weill Cornell Medical College, [said]. “In turn,” he continued “[this] may increase the survival rate." Researchers found mice implanted with cancer cells and treated with the small molecule macroketone lived a full life without any cancer spread, compared to control animals -- which all died from metastasis. Dr. Huang and his team have been focusing on macroketone since 2003, and he admits to being extremely excited about the future possibilities for his research. While information-gathering is still in its early stages, Dr. Huang says it’s possible his team could get the green light for clinical trials in the near future.
Note: For more on this exciting development, click here. And why isn't this getting fast-track approval for studies? To learn how cancer cures which threaten billions in pharmaceutical losses are supressed, click here.
A vegetarian diet may help to protect against cancer, a UK study suggests. Analysis of data from 52,700 men and women shows that those who did not eat meat had significantly fewer cancers overall than those who did. Writing in the American Journal of Clinical Nutrition the team said the findings were worth looking into. Although it is widely recommended that people eat five portions of fruit and vegetables a day to reduce their risk of cancer and other diseases, there is very little evidence looking specifically at a vegetarian diet. In the latest study, researchers looked at men and women aged 20 to 89 recruited in the UK in the 1990s. They divided participants into meat-eaters, fish-eaters, vegetarians and vegans. During follow-up there were fewer cancers than would be expected in the general population - probably because they were a healthier than average group of people. But there was a significantly lower incidence of all cancers among the fish-eaters and vegetarians compared with the meat eaters. For colorectal cancer, however that trend was reversed with vegetarians having a significantly higher incidence of the condition than the other groups.
Note: For many promising reports from major media sources on potential cancer cures, click here.
Doctors have known that low levels of vitamin D are linked to certain kinds of cancers as well as to diabetes and asthma, but new research also shows that the vitamin can kill human cancer cells. The results fall short of an immediate cancer cure, but they are encouraging, medical professionals say. JoEllen Welsh, a researcher with the State University of New York at Albany, has studied the effects of vitamin D for 25 years. Part of her research involves taking human breast cancer cells and treating them with a potent form of vitamin D. Within a few days, half the cancer cells shriveled up and died. Welsh said the vitamin has the same effect as a drug used for breast cancer treatment. "Vitamin D enters the cells and triggers the cell death process," she [said]. "It's similar to what we see when we treat cells with Tamoxifen," a drug used to treat breast cancer. The vitamin's effects were even more dramatic on breast cancer cells injected into mice. After several weeks of treatment, the cancer tumors in the mice shrank by an average of more than 50 percent. Some tumors disappeared. Similar results have been achieved on colon and prostate cancer tumors in mice.
For the first time in 20 years, a government panel is telling women in their [forties] to stop getting routine mammograms and recommending that a host of other breast cancer screenings slow down. The United States Preventive Service Task Force announced ... that it recommends against annual mammograms for women age 40 to 49 because, they say, the benefits of testing do not outweigh the "harms" and risks. USPSTF still recommends doctors start screening all women over age 50, but with a mammogram once every two years instead of annually. The task force also ... said evidence was insufficient to recommend mammograms for women older than 74. The recommendations announced today, which contradict the American Cancer Society, have already pitted doctors, women, insurers and radiology groups in a fierce debate about who should get a mammogram and when. Many patient advocates wonder if money fueled the decision. However, Dr. Diana Petitti, vice chair of USPSTF, said the task force never looked at costs in their research or their recommendations. Instead, the task force reviewed a number of studies to compile the benefits of mammograms, such as how many cancers were detected and how many lives were saved, and the harms of mammograms, such as how many false positives popped up, how many unnecessary tests were done and how much extra radiation women were exposed to during the false positive testing.
Note: For a powerful article compiling important information and key quotes of doctors and researchers revealing the dangers of mammograms, click here.
Suzanne Somers is at it again. She's back with a new book [on an] emotional topic: Cancer treatment. Specifically, she argues against what she sees as the vast and often pointless use of chemotherapy. Somers, who has rejected chemo herself, seems to relish the fight. "Cancer's an epidemic," said the 63-year-old actress ... a day before [the] release of Knockout: Interviews with Doctors Who Are Curing Cancer--And How to Prevent Getting It in the First Place, her 19th book. "And yet we keep going back to the same old pot, because it's all we've got. Well, this is a book about options." Though she may be one of the most visible, Somers is hardly the only celebrity who's advocated alternative treatments recently. The late Farrah Fawcett underwent a mix of traditional and alternative treatments, and made a poignant plea for supporting alternative methods in her film, "Farrah's Story." Actress Jenny McCarthy advocates a special dietary regime, supplements, metal detox and delayed vaccines to treat autism. In fact, Somers does view chemotherapy as effective for some cancers, but not for the most common, including lung and breast cancer. Diagnosed with breast cancer a decade ago, she had a lumpectomy and radiation, but declined chemotherapy, as she did more recently when briefly misdiagnosed with pervasive cancer.
Note: To watch a video clip of this, click here. For her harrowing experience of being misdiagnosed with stage four cancer, click here. And if you want to understand how big money sometimes ruthlessly acts to stop cancer cures, click here. For media articles discussing potentially powerful cancer cures and how industry sometimes will not support them, click here.
In a study, researchers have found that long-term pot smokers were roughly 62 percent less likely to develop head and neck cancers than people who did not smoke pot. The new study featured 434 patients with head and neck cancers, which include tumors in the mouth, tongue, nose, sinuses, throat and lymph nodes in the neck, and 547 individuals without these cancers seen in the Greater Boston area from December 1999 to December 2003. After factoring out the impact of smoking, drinking, and other factors that might influence the results, smoking marijuana from once every two weeks to three times every two weeks, on average, was associated with about half the risk of head and neck cancer, compared with less frequent use. Those who took up pot smoking at an older age appeared to have less risk of these cancers than those who started it at a younger age. Compared to people who never smoked pot, those who began smoking marijuana between the ages of 15 and 19 years were 47 percent less likely to develop head and neck cancer, while users who began at age 20 or older had a 61 percent reduced risk, Kelsey and colleagues found. The authors note that chemicals in pot called cannabinoids have been shown to have potential antitumor effects. Other studies have linked marijuana use to a reduced risk of some cancers, such as cancer of the prostate, and now head and neck cancer. It's also been suggested that smoking pot may help stave off Alzheimer's disease and help combat weight loss associated with AIDS, and nausea and vomiting associated with chemotherapy in cancer patients.
Note: For a great nine-minute video presenting major media reports showing how marijuana is a very promising cancer treatment that is being suppressed, click here. For deeply revealing reports from reliable major media sources on health issues, click here.
Spontaneous tumor regressions are among the rarest and most mysterious events in medicine, with only several hundred cases in the literature that can be considered well documented. Regressions have most often been reported in melanoma and in kidney cancer. But the phenomenon may, in fact, be an everyday one, taking place beyond doctors' eyes. A recent study suggests that as many as 1 in 3 breast tumors may vanish on their own before being detected by a doctor. Why do some patients get lucky? Scientists are finding tantalizing evidence that the immune system, the body's defense against disease-causing microbes, kicks in to play a critical role in combating cancer. The evidence includes the fact that some unexplained remissions have occurred after infections, which may propel the immune system into high gear--possibly attacking the cancer tumor as well as the infection. The role of the immune system in controlling cancer has been hotly debated for decades--and indeed many scientists remain unconvinced. But Jedd D. Wolchok, an oncologist at New York's Memorial Sloan-Kettering Cancer Center, thinks there is a connection. A spontaneous remission, he says, is "either divine intervention or the immune system." While few researchers directly study such cases--they are far too rare--they provide hints of what the immune system might be able to do if we could harness it.
Note: The number of these cancer miracles are likely far more than suggested in this article. The problem is that most doctors ignore or consider them insignificant. For a most fascinating example of this, click here. For many exciting reports from major media sources describing potentially promising new cancer treatments, click here.
An extract from grape seeds can destroy cancer cells, US research suggests. In lab experiments, scientists found that the extract stimulated leukaemia cells to commit suicide. Within 24 hours, 76% of leukaemia cells exposed to the extract were killed off, while healthy cells were unharmed, Clinical Cancer Research reports. The study raises the possibility of new cancer treatments, but scientists said it was too early to recommend that people eat grapes to ward off cancer. Grape seeds contain a number of antioxidants, including resveratrol, which is known to have anti-cancer properties, as well as positive effect on the heart. Previous research has shown grapeseed extract has an effect on skin, breast, bowel, lung, stomach and prostate cancer cells in the laboratory. It can also reduce the size of breast tumours in rats and skin tumours in mice. However, the University of Kentucky study is the first to test its impact on a blood cancer. Lead researcher Professor Xianglin Shi said: "These results could have implications for the incorporation of agents such as grapeseed extract into prevention or treatment of haematological (blood) malignancies and possibly other cancers. What everyone seeks is an agent that has an effect on cancer cells but leaves normal cells alone, and this shows that grapeseed extract fits into this category."
Note: For lots more on promising new cancer research findings from major media sources, click here.
Cancer researchers have known for years that it was possible in rare cases for some cancers to go away on their own. There were occasional instances of melanomas and kidney cancers that just vanished. And neuroblastoma, a very rare childhood tumor, can go away without treatment. But these were mostly seen as oddities — an unusual pediatric cancer that might not bear on common cancers of adults, a smattering of case reports of spontaneous cures. And since almost every cancer that is detected is treated, it seemed impossible even to ask what would happen if cancers were left alone. Now, though, researchers say they have found a situation in Norway that has let them ask that question about breast cancer. And their new study, to be published Tuesday in The Archives of Internal Medicine, suggests that even invasive cancers may sometimes go away without treatment and in larger numbers than anyone ever believed. Robert M. Kaplan, the chairman of the department of health services at the School of Public Health at the University of California, Los Angeles, [is] persuaded by the analysis. The implications are potentially enormous, Dr. Kaplan said. If the results are replicated, he said, it could eventually be possible for some women to opt for so-called watchful waiting, monitoring a tumor in their breast to see whether it grows. “People have never thought that way about breast cancer,” he added. Dr. Kaplan and his colleague, Dr. Franz Porzsolt, an oncologist at the University of Ulm, said in an editorial that accompanied the study, “If the spontaneous remission hypothesis is credible, it should cause a major re-evaluation in the approach to breast cancer research and treatment.”
Note: For reports from major media sources on many hopeful new developments in the battle against cancer, click here.
There is an epidemic of cancer today. One in three Americans will be diagnosed with cancer, often before the age of 65. Since 1940, we have seen in Western societies a marked and rapid increase in common types of cancer. In fact, cancer in children and adolescents has been rising by 1 to 1.5 percent a year since the 1960's. And these are cancers for which there is no screening. For most common cancers - prostate, breast, colon, lung - rates are much higher in the West than in Asian countries. Yet Asians who emigrate to the United States catch up with the rates of Americans within one or two generations. While in Asia, Asians are protected not by their genes, but by their lifestyle. We continue to invest 97 percent of our cancer research funds in better treatments and early detection. Only 3 percent is invested in tackling causes. The World Cancer Research Fund published a report in 2007 concluding that a majority of cancer cases in Western societies could be avoided with life-style measures: 40 percent from changes in diet and physical activity (more vegetables and fruits, less sugar, less red meat, regular walking or the equivalent activity 30 minutes six times per week), 30 percent from smoking cessation, and about 10 percent from reduced alcohol consumption. We now even have data about how specific foods such as broccoli and cabbages, garlic and onions, green tea or the spice turmeric directly help kill cancer cells and reduce the growth of new blood vessels they need to develop into tumors.
Note: The author of this article, Dr. David Servan-Schreiber, is a clinical professor of psychiatry at the University of Pittsburgh and a founding board member of Doctors Without Borders, USA, and author of Anticancer - A new way of life. For an excellent, inspiring 10-minute video interview with this doctor, click here.
In a major breakthrough in the search for a cure for cancer, the first human trials are to begin using a technique that has already been shown to destroy the disease in mice. The trials are the culmination of years of research prompted by the discovery of a cancer-proof mouse by researchers almost a decade ago. More than 20 cancer patients will be given white blood cells with cancer-killing properties in an attempt to boost their immune system's fight against the deadly illness. The work stems from experiments into the metabolism of a humble laboratory mouse whose immunity to cancer defied the repeated attempts of scientists to kill it with high-level doses of cancer cells. White blood cells taken from the animal and its offspring were subsequently used to cure other mice of advanced cancers. The white blood cells destroyed the cancer cells but left normal cells alone. This discovery encouraged scientists to study how people might be helped to fight off cancer by being given a boost of white blood cells called granulocytes. Laboratory tests have since shown how human granulocytes can destroy cervical, prostate and breast cancer cells, provided sufficient numbers of cancer-killing granulocytes from healthy donors are used. Scientists are now confident that the treatment will prove just as successful in humans as it has been in mice. Hundreds of donors will be recruited for the new treatment – which is called leukocyte infusion therapy – and a process similar to platelet donation will be used to collect the granulocytes.
A man who had been given less than a year to live had a complete remission of advanced deadly skin cancer after an experimental treatment that revved up his immune system to fight the tumors. The 52-year-old patient's dramatic turnaround was the only success in a small study, leading doctors to be cautious in their enthusiasm. However, the treatment reported in ... The New England Journal of Medicine is being counted as the latest in a small series of successes involving immune-priming treatments against deadly skin cancers. "Immunotherapy has become the most promising approach" to late-stage, death-sentence skin cancers, said Dr. Darrell Rigel, a dermatology researcher at the New York University Cancer Institute in New York. About 20 years ago, some scientists discovered that immune cells could latch onto and attack skin cancers. "There's a long history behind all of this," said Dr. Steven Rosenberg of the National Cancer Institute. In recent experiments, Rosenberg and other researchers have focused on souping up a certain kind of immune system cell - the "killer T cells" that envelop and kill foreign agents. Scientists focused ... on specific helper T cells that are adept at locking onto a cancer cell and guiding the killer cells to their target. The researchers drew blood from patients, located the special helper cells and then grew more of them in the laboratory. They then infused roughly 5 billion of the cells back into the patients without chemotherapy or the other harsh drugs. "It's a simpler and less toxic approach to melanoma than had been previously employed," said Dr. Louis Weiner, director of the cancer center at Georgetown University.
Note: For many hopeful reports on potential new cancer cures, click here.
The last thing John Kanzius thought he'd ever do was try to cure cancer. A former radio and television executive from Pennsylvania, he came to Florida to enjoy his retirement. "I have no business being in the cancer business. It's not something that a layman like me should be in, it should be left to doctors and research people," he told [CBS] correspondent Lesley Stahl. It was the worst kind of luck that gave Kanzius the idea to use radio waves to kill cancer cells: six years ago, he was diagnosed with terminal leukemia and since then has undergone 36 rounds of toxic chemotherapy. But it wasn't his own condition that motivated him, it was looking into the hollow eyes of sick children on the cancer ward at M.D. Anderson Cancer Center in Houston. "I saw the smiles of youth and saw their spirits were broken. And you could see that they were ... asking, 'Why can't they do something for me?'" Kanzius told Stahl. "And I said, 'There's got to be a better way to treat cancer.'" It was during one of those sleepless nights that the light bulb went off. When he was young, Kanzius was one of those kids who built radios from scratch, so he knew the hidden power of radio waves. Sick from chemo, he got out of bed, went to the kitchen, and started to build a radio wave machine. "Started looking in the cupboard and I saw pie pans and I said, 'These are perfect. I can modify these,'" he recalled. His wife Marianne woke up that night to a lot of banging and clamoring. "I was concerned truthfully that he had lost it," she told Stahl. "She felt sorry for me," Kanzius added. "I did," Marianne Kanzius acknowledged. "And I had mentioned to him, 'Honey, the doctors can't-you know, find an answer to cancer. How can you think that you can?'" That's what 60 Minutes wanted to know, so Stahl went to his garage laboratory to find out.
Note: This CBS News report was broadcast on 60 Minutes. To watch the video of the broadcast, click on the link above.
Vitamin D-binding protein-derived macrophage activating factor (GcMAF) appears to be an effective immunotherapeutic agent in patients with metastatic breast cancer, according to US and Japanese researchers. "Serum vitamin D-binding protein -- known as Gc protein -- is the precursor of the principal macrophage activating factor," lead investigator Dr. Nobuto Yamamoto told Reuters Health. "Treatment of purified Gc protein with beta-galactosidase and sialidase generates GcMAF," he added, "the most potent macrophage activating factor ever discovered, which produces no side effect in humans." Dr. Yamamoto of the Socrates Institute for Therapeutic Immunology, Philadelphia and colleagues note that in vitro studies show that macrophages treated with GcMAF have a highly tumoricidal effect in mammary adenocarcinomas. To investigate whether the approach can be effective in humans, the researchers studied 16 non-anemic breast cancer patients who were given "a minute amount -- 100 nanograms per week -- of GcMAF," Dr. Yamamoto said. The researchers found that after 16 to 22 GcMAF doses, initially elevated nagalase levels, which reflect the tumor burden, fell to those found in healthy controls. Follow-up over 4 years showed that the level remained low and that there was no tumor recurrence, they report in the January 15th issue of The International Journal of Cancer. The findings, the team concludes, clearly demonstrate "the importance of focusing cancer immunotherapy on macrophage activation."
Note: Another article from the National Institutes of Health website covers an experiment with colorectal cancer patients using this amazing discovery. It states that "all colorectal cancer patients exhibited healthy control levels of the serum Nagalase activity, indicating eradication of metastatic tumor cells." Why isn't this getting more major press coverage?
Today, some scientists think [that] germs can teach our bodies how to fight back against tumors. Dr. John Timmerman, a cancer immunotherapy expert at UCLA's Jonsson Cancer Center, says this revolution has produced "the most exciting sets of compounds in cancer immunology." New studies are revealing that certain cancers may be reduced by exposure to disease-causing bacteria and viruses. The studies also imply that our cleaner, infection-free lifestyles may be contributing to the rise in certain cancers over the last 50 years, scientists say, because they make the immune system weaker or less mature. Germs cause disease but may also fortify the body, a notion summed up in a 2006 report by a team of Canadian researchers as "whatever does not kill me makes me stronger." In the 1980s, dermatologists began noticing that patients with severe acne, which is caused by another type of bacterium, have reduced rates of skin cancer, lymphoma and leukemia. According to a paper by Dr. Mohammad Namazi at the Shiraz University of Medical Sciences in Iran, studies showed that these bacteria, when injected into animals, appear to stimulate the immune system and shrink tumors. In reports published in the last two years, Harvey Checkoway, a University of Washington epidemiologist, has found that female cotton workers in Shanghai have a 40% to 60% lower risk of lung, breast, and pancreas cancer than other factory workers. Other recent studies by Giuseppe Mastrangelo at the University of Padua in Italy found that dairy farmers exposed to high levels of manure dust are up to five times less likely to develop lung cancer than their colleagues who work in open fields.
Note: For exciting reports of promising new approaches to curing cancer, click here.
Last winter, inventor John Kanzius was already attempting one seemingly impossible feat -- building a machine to cure cancer with radio waves -- when his device inadvertently succeeded in another: He made saltwater catch fire. TV footage of his bizarre discovery has been burning up the blogosphere ever since, drawing crackpots and Ph.D.s alike into a raging debate. Can water burn? And if so, what good can come of it? Some people gush over the invention's potential for desalinization or cheap energy. Briny seawater, after all, sloshes over most of the planet's surface, and harnessing its heat energy could power all sorts of things. Skeptics say Kanzius's radio generator is sucking up far more energy than it's creating, making it a carnival trick at best. For now, Kanzius is tuning out the hubbub. Diagnosed with leukemia in 2002, he began building his radio-wave blaster the next year, soon after a relapse. If he could seed a person's cancerous cells with nanoscopic metal particles and blast them with radio waves, perhaps he could kill off the cancer while sparing healthy tissue. The saltwater phenomenon happened by accident when an assistant was bombarding a saline-filled test tube with radio waves and bumped the tube, causing a small flash. Curious, Kanzius struck a match. "The water lit like a propane flame," he recalls. "People said, 'It's a crock. Look for hidden electrodes in the water,' " says Penn State University materials scientist Rustum Roy, who visited [Kanzius] in his lab in August after seeing the feat on Google Video. A demo made Roy a believer. "This is discovery science in the best tradition," he says. Meanwhile, researchers at MD Anderson Cancer Center in Houston and the University of Pittsburgh Medical Center have made progress using Kanzius's technology to fight cancer in animals. They published their findings last month in the journal Cancer.
Note: For other compelling articles on this fascinating invention, see recent articles in the Los Angeles Times, ABC News, and especially Medical News Today. And for dozens of astounding major media articles showing clear suppression of potential cancer cures, click here.
In what a dying Rick Smalley called the most important application from his Nobel Prize-winning discovery [of fullerines], Houston researchers are using [carbon] nanotubes heated by radio waves to kill cancer cells. In a paper posted online by the journal Cancer, a team at the University of Texas M.D. Anderson Cancer Center and Rice University reported that the technique destroyed liver cancer tumors in rabbits and caused no side effects. It is thought to hold the same potential for many other cancers. "I don't want to overstate matters — I'm the biggest skeptic in the world — given the challenges still ahead of us," Dr. Steven Curley, an M.D. Anderson surgical oncologist and the paper's senior author, said Thursday. "But my hope is that this will be a very useful tool to safely and efficiently treat a lot of types of cancer." The therapy marries two disparate disciplines: the relatively ancient field of radio waves and nanotechnology, the cutting-edge science of the ultra-small. The rabbit study found the therapy worked only when the two were used together. It works not by poisoning but by creating a localized hyperthermia — or small fever — that destroys the cancer cells' membranes, protein and even DNA. The cells then die and are carried out of the body through normal kidney functions. In the experiment recounted in Cancer, the rabbits were injected with a solution of single-walled carbon nanotubes — hollow cylinders of pure carbon measuring about a billionth of a meter across — then exposed to two minutes of radio-frequency treatment. The result, researchers said, was the thermal destruction of 100 percent of the tumors. The idea was inspired by John Kanzius, an M.D. Anderson leukemia patient and retired Pennsylvania radio and television station owner. He developed a radio-frequency generator after undergoing chemotherapy and noting its effect on himself and other patients.
Note: For many hopeful new developments in the search for cancer cures, click here.
Sunbathing, considered risky by skin cancer experts, may actually reduce the risk of breast and other cancers, new research has found. Some women who had higher sun exposure had their risk of advanced breast cancer reduced by almost half, according to the scientific study. The researchers from Stanford University, who report their findings in the American Journal of Epidemiology this week, said: "This study supports the idea that sunlight exposure reduces risk of advanced breast cancer among women with light skin pigmentation." The Stanford cancer specialists measured 4,000 women aged 35 to 79, half of them diagnosed with breast cancer, for the effects of long-term sun exposure. Sun exposure may also protect against a number of other cancers, according to a second research team who studied more than four million people in 11 countries, including 416,000 who had been diagnosed with skin cancer. These results, reported in the European Journal of Cancer, show that the risk of internal cancers ... was lower among people living in sunny countries. The researchers said: "Vitamin D production in the skin seems to decrease the risk of several solid cancers, especially stomach, colo-rectal, liver and gall- bladder, pancreas, lung, female breast, prostate, bladder and kidney cancers." Sunlight plays a vital role in the production of beneficial vitamin D in the body. Although food provides some vitamin D, up to 90 per cent comes from exposure to sunlight.
Note: For many reliable, verifiable reports on promising cancer cures, click here.
For most, a cancer diagnosis can be devastating. But for John Kanzius it was a call to action. Kanzius isn't a doctor. He doesn't even have a college degree. Yet ... the device he invented has impressed a notable researcher and inspired his hometown, Erie, Pa., to the point where it gave him a key to the city in April. Asked by [a reporter] what made him think he could cure cancer, Kanzius replied with a laugh, "Nobody else was doing it! I envision this treatment taking no more than a couple of minutes or so." Kanzius hopes cancer treatments could work something like this: A patient would be injected with tiny metal nano-particles, which would be carried through the bloodstream by a targeting molecule and attach only to cancerous cells. The patient would then be exposed to an energy field created by radio waves, and feel nothing, while the nano-particles would generate enough heat to destroy their cancerous host cell. Kanzius demonstrated just how easily the nano-particles could be used as receivers. A lab worker injected carbon nano-particles into a specific spot in a piece of liver, which was then placed into an energy field of low frequency radio waves. Within seconds, the areas injected the with nano-particles were heated to the point of actually cooking the liver, while leaving the surrounding meat unscathed. Kanzius' invention has caught the attention of Dr. Steven Curley, a surgical oncologist and cancer researcher at MD Anderson Cancer Center in Houston. "This has the most fascinating potential I've seen in anything in my twenty years of cancer research," Curley [said]. Curley has developed current methods of using radio frequencies to attack cancer, but says he looks forward to one day using a non-invasive approach like the one Kanzius is working on.
Note: For a treasure trove of reliable information about exciting possible cancer cures, click here.
In laboratory experiments, a team at the University of Glasgow simulated what happens in the human stomach. They found vitamin C (ascorbic acid) mopped up potential cancer-causing compounds that are made when saliva and food mixes with stomach acid. But when they added fat to the mix, the ascorbic acid could no longer convert the hazardous compounds into safe ones. Antioxidants like ascorbic acid protect against the formation of (carcinogenic) nitrosocompounds by converting the nitrosating species into nitric oxide. However, when fat is present, it reacts with the nitric oxide to reform nitrosating species, the scientists found. Bridget Aisbitt, nutrition scientist for the British Nutrition Foundation, said: ... "This research is interesting." She said fat-compatible antioxidants in the body, such as beta-carotene, could also neutralise the nitrosocompounds. This is another reason to underline the importance of a healthy balanced diet where meals high in fat should not be frequent and five portions of fruit and vegetables - our main source of vitamin C - are eaten each day.
Note: Why isn't it being widely reported the Vitatmin C and beta-carotene are effective cancer fighters? For a possible answer by one of the top physicians in the U.S., click here.
We could make faster progress against cancer by changing the way drugs are developed. In the current system, if a promising compound can’t be patented, it is highly unlikely ever to make it to market — no matter how well it performs in the laboratory. The development of new cancer drugs is crippled as a result. The reason for this problem is that bringing a new drug to market is extremely expensive. In 2001, the estimated cost was $802 million; today it is approximately $1 billion. To ensure a healthy return on such staggering investments, drug companies seek to formulate new drugs in a way that guarantees watertight patents. In the meantime, cancer patients miss out on treatments that may be highly effective and less expensive to boot. In 2004, Johns Hopkins researchers discovered that an off-the-shelf compound called 3-bromopyruvate could arrest the growth of liver cancer in rats. The results were dramatic; moreover, the investigators estimated that the cost to treat patients would be around 70 cents per day. Yet, three years later, no major drug company has shown interest in developing this drug. The hormone melatonin, sold as an inexpensive food supplement in the United States, has repeatedly been shown to slow the growth of various cancers when used in conjunction with conventional treatments. Early this year, another readily available industrial chemical, dichloroacetate, was found by researchers at the University of Alberta to shrink tumors in laboratory animals by up to 75 percent. However ... dichloroacetate is not patentable, and the lead researcher is concerned that it may be difficult to find funding from private investors to test the chemical. Potential anticancer drugs should be judged on their scientific merit, not on their patentability.
Note: To explore several cancer cures which have shown dramatic potential, yet are not being studied for lack of funds due to inability to patent the process, click here. Why are these very promising treatments not being fast-tracked as the expensive AIDS drugs were? For a top MD's revealing comments on this, click here. And for why the media won't feature these promising cancer treatments in headlines, click here.
A Florida man with no medical training has invented a machine that he believes may lead to a cure for cancer. John Kanzius ... wondered if his background in physics and radio could come in handy in treating the disease from which he suffers himself. After 24 rounds of chemotherapy, the former broadcaster decided that he did not want to see others suffer trying to cure the disease. Kanzius said it was watching kids being treated that affected him the most. "Particularly, young children walk in with smiles, and then you'd see them three weeks later and their smiles had disappeared. I said to myself, 'We're in a barbaric type of medicine." Kanzius said his machine basically makes cells act like antennae to pick up a signal and self-destruct. Unlike current cancer treatment, Kanzius' machine does not use radiation, and unlike today's radio-frequency treatments, it's noninvasive. Now, some of the nation's most prominent doctors and scientists are using Kanzius' machines in their research. In January, researchers said they performed a breakthrough at the M. D. Anderson Cancer Center in Houston. "The complete killing of pancreatic cells in laboratory conditions is encouraging," Dr. Steve Curley said. Kanzius explained that his machine uses a solution filled with nanoparticles, which measure no more than one-billionth of a meter. A test subject would be injected with either gold or carbon nanoparticles, which would make their way through the body and attach to the cancerous cells. The test subject would then enter the machine and receive a dose of radio frequency waves, theoretically heating and killing the cancerous cells in moments and leaving nearby cells untouched.
There are no magic bullets in the fight against cancer: that's the first thing every responsible scientist mentions when discussing a possible new treatment, no matter how promising. If there were a magic bullet, though, it might be something like dichloroacetate, or DCA, a drug that kills cancer cells by exploiting a fundamental weakness found in a wide range of solid tumors. So far, though, it kills them just in test tubes and in rats infected with human cancer cells; it has never been tested against cancer in living human beings. DCA ... is an existing drug whose side effects are well-studied and relatively tolerable. Also, it's a small molecule that might be able to cross the blood-brain barrier to reach otherwise intractable brain tumors. Within days after a technical paper on DCA appeared in the journal Cancer Cell last week, the lead author, Dr. Evangelos Michelakis of the University of Alberta, was deluged with calls and e-mails from prospective patients—to whom he can say only, “Hang in there.” DCA is a remarkably simple molecule. It acts in the body to promote the activity of the mitochondria. Researchers have assumed that the mitochondria in cancer cells were irreparably damaged. But Michelakis wondered if that was really true. With his colleagues he used DCA to turn back on the mitochondria in cancer cells—which promptly died. One of the great things about DCA is that it's a simple compound, in the public domain, and could be produced for pennies a dose. But that's also a problem, because big drug companies are unlikely to spend a billion dollars or so on large-scale clinical trials for a compound they can't patent.
Note: Read a 2010 follow-up by Dr. Michelakis with promising results and watch a 10-minute video. Explore the DCA website. Why didn't other mass media report this major story? Why aren't many millions of dollars being poured into research? Notice even Newsweek acknowledges the drug companies are not interested in finding a cure for cancer if they can't make a profit from it. Some suspect the drug companies have even suppressed cancer cures found in the past. See one amazing example of this. For more, see these major media articles on potential cancer cures.
In results that "astounded" scientists, an inexpensive molecule known as DCA was shown to shrink lung, breast and brain tumours in both animal and human tissue experiments. The study was published yesterday in the journal Cancer Cell. "I think DCA can be selective for cancer because it attacks a fundamental process of cancer that is unique to cancer cells," said Dr. Evangelos Michelakis, a professor at the Edmonton university's medical school and one of the study's key authors. The molecule appears to repair damaged mitochondria in cancer cells. "When a cell is getting too old or doesn't function properly, the mitochondria are going to induce the cell death," lead study author Sebastien Bonnet said yesterday. Bonnet says DCA – or dichloroacetate – appears to reverse the mitochondrial changes in a wide range of cancers. "One of the really exciting things about this compound is that it might be able to treat many different forms of cancer because all forms of cancer suppress mitochondrial function," Michelakis said. Bonnet says DCA may also provide an effective cancer treatment because its small size allows easy absorption into the body, ensuring it can reach areas that other drugs cannot, such as brain tumours. Because it's been used to combat other ailments ... DCA has been shown to have few toxic effects on the body. Its previous use means it can be immediately tested on humans. Unlike other cancer drugs, DCA did not appear to have any negative effect on normal cells. It could provide an extremely inexpensive cancer therapy because it's not patented. But ... the lack of a patent could lead to an unwillingness on the part of pharmaceutical companies to fund expensive clinical trials.
Note: Even these scientists realize that though this discovery could be a huge benefit to mankind, because the drug companies will lose profits, they almost certainly will not fund studies. Expensive AIDS drugs with promising results, on the other hand, are rushed through the studies to market. For more reliable, verifiable information on how hugely beneficial health advances are shut down to keep profits high, click here and here.
A Toronto-led team of researchers has discovered a trigger for Type 1 diabetes, a breakthrough that has long evaded scientists and could lead the way to preventing the disease. The team found that abnormal nerve endings in the insulin-producing cells of the pancreas initiated a chain of events that caused Type 1 diabetes in mice. When they removed the nerve cells, the mice did not develop the disorder. That means diabetes may be a disease of the nervous system, not just an autoimmune disease, said Dr. Hans Michael Dosch, a senior scientist at the Hospital for Sick Children and the study's main investigator. In a reversal of what they expected, the researchers also found injecting substance P — a chemical secreted by nerve cells — into mice whose islet cells were inflamed and on the way to being destroyed not only eliminated the inflammation but reversed it. "The blood glucose normalizes overnight and it stays low for weeks to months — this is with a single shot," Dosch said. "We now have 4-month-old mice that are non-diabetic that used to be diabetic" — a period equivalent to six to eight years in humans. Experts say the findings, reported yesterday in the journal Cell, will change the way scientists think about diabetes. "It really is a breakthrough for the diabetes community," said Pam Ohashi, a professor of immunology at the University of Toronto. Dosch has immediate plans to move his research from mice to humans. He is launching a clinical trial in January to figure out if patients who have a high risk of Type 1 diabetes have the same sensory nerve abnormalities. "If they do, then we have fantastic new therapeutic strategies," said Dosch, who is also a professor of pediatrics and immunology at U of T.
Note: The pharmaceutical industry makes huge profits from diabetics. Big profits have been known to prevent cures from making it to market. Click here for more. Let's hope this important research moves forward.
Government nutrition researcher [Dr. Mark Levine] has published new evidence that suggests vitamin C can work like chemotherapy - only better. But so far, he hasn't been able to interest cancer experts in conducting the kind of conclusive studies that, one way or the other, would advance treatment. "If vitamin C is useful in cancer treatment, that's wonderful. If it's not, or if it's harmful, that's fine, too," said Levine, a Harvard-educated physician at the National Institute of Diabetes and Digestive and Kidney Diseases. The distinction between oral and intravenous is crucial. The body automatically gets rid of extra C through urine. Levine's lab has shown that, at high concentrations, the vitamin is toxic to many types of cancer cells in lab dishes. But to get that much C into the body before it's eliminated, it must be put directly into the blood. Five out of nine types of cancer cells that were put in simulated body-cavity fluid died when concentrated ascorbate or peroxide was added to the dish. And the best part: This same lethal marinade had no effect on healthy cells. "Interest is definitely growing," said Kenneth Bock, physician and president of the American College for Advancement in Medicine, an alternative-medicine society that teaches ascorbate infusion protocols. The American Cancer Society and the American Association of Clinical Oncologists warn patients against high-dose C, as do leading cancer centers such as the University of Pennsylvania's and Memorial Sloan-Kettering.
White blood cells from mice that are naturally immune to cancer cured tumors in other mice and provided them with lifelong immunity to the disease, researchers reported Monday. The finding indicates the existence of a biological pathway previously unsuspected in any species. A small team of researchers is working to understand the genetic and immunological basis of the surprising phenomenon. Preliminary studies hint at the existence of a similar resistance in humans. Researchers hope that harnessing the biological process could lead to a new approach to treating cancer. But Dr. Zhen Cui of Wake Forest, whose team published the findings in the Proceedings of the National Academy of Science, said he expected rapid replication of the results because the findings were so clear-cut and easily observed. "This is a truly remarkable phenomenon -- and it really needs confirmation from other institutions," he said. The team took white blood cells from the immune mice ... and injected them into mice already carrying a variety of tumors, some of which were extremely aggressive. In every case, the cancers were destroyed, even if the cells were injected at a point distant from the tumor. Healthy tissues were not affected. The mice that received the cells, furthermore, were protected from new tumors for the rest of their lives. The researchers have no idea how the immunity continues.
Note: Why was this not in the headlines and not given a title like "Cancer Cure Found for Mice"? Most major papers didn't even report the story, and an article in the New York Times was titled simply "A Strain of Mice Appears Able to Resist Cancer Cells." Could it be that the power brokers in the medical industry know that a cancer cure would cause huge financial losses for them? For what happened to an incredible scientist in the past who discovered a cancer cure for humans, click here.
A common virus that is harmless to people can destroy cancerous cells in the body and might be developed into a new cancer therapy, US researchers said. The virus, called adeno-associated virus type 2, or AAV-2, infects an estimated 80 percent of the population. "Our results suggest that adeno-associated virus type 2, which infects the majority of the population but has no known ill effects, kills multiple types of cancer cells yet has no effect on healthy cells," said Craig Meyers, a professor of microbiology and immunology at the Penn State College of Medicine in Pennsylvania. "We believe that AAV-2 recognizes that the cancer cells are abnormal and destroys them. This suggests that AAV-2 has great potential to be developed as an anti-cancer agent," Meyers said in a statement. AAV-2 is a small virus that cannot replicate itself without the help of another virus. But with the help of a second virus it kills cells. For their study, Meyers and colleagues first infected a batch of human cells with HPV, some strains of which cause cervical cancer. They then infected these cells and normal cells with AAV-2. After six days, all the HPV-infected cells died. The same thing happened with cervical, breast, prostate and squamous cell tumor cells. "One of the most compelling findings is that AAV-2 appears to have no pathologic effects on healthy cells," Meyers said. "So many cancer therapies are as poisonous to healthy cells as they are to cancer cells. A therapy that is able to distinguish between healthy and cancer cells could be less difficult to endure for those with cancer."
Note: For more on promising cancer cures, see the deeply revealing reports from reliable major media sources available here.
An ancient native American treatment for cancer has been shown to have a beneficial effect despite scepticism from the medical establishment. Chaparral, an evergreen desert shrub, has long been used by native Americans to treat cancer, colds, wounds, bronchitis, warts, and ringworm. But experts dismissed its worth, and warned it could be dangerous. Now researchers at the Medical University of South Carolina have shown an extract may shrink some tumours. Chaparral tea was widely used in the US as an alternative anti-cancer agent from the late 1950s to the 1970s. However, the American Cancer Society said there was no proof that it was an effective treatment for cancer - or any other disease. And the US Food and Drug Administration warned against its use after research showed it could damage the liver and the kidneys. However, initial results from the latest study show that an extract of the shrub appears not only to be safe, but to have a positive effect. The researchers tested a refined extract taken from chaparral called M4N. They injected it into the tumours of eight patients with advanced head and neck cancer that had not responded to other forms of treatment. The results were encouraging - patients seemed to tolerate it well, and there was no evidence of the serious liver damage previously associated with chaparral use. The study also produced some evidence that the extract had begun to shrink the tumours.
Over a period of 30 years, highly qualified Perth-based surgeon Dr John Holt has had some startling successes with a radio-wave therapy treatment for cancer patients. Dr Holt's controversial treatment works, in layperson's terms, by giving the patient an injection of a glucose-blocking agent. He then shines "radio waves" into the body at a specific frequency. Dr Holt doesn't guarantee it will cure every cancer, but it's not expensive and there's no quackery about it. Born in Bristol 80 years ago and a member of the Royal Colleges, Dr Holt has 26 medical letters after his name. For more than a decade he was in charge of Western Australia's main cancer institute, until the late '70s, when he was blacklisted by his medical colleagues and politicians. The polarisation of the medical and scientific community in Perth over Dr Holt's treatment has been evident since the mid-'70s. While the medical community continues to argue the merits of Dr Holt's unorthodox measures, the families of his successes feel they owe everything to this gentle man. After two brain tumours and a tumour on her spine, Sophia Rosa was sent by pre-eminent brain surgeon Dr Charlie Teo for the radical treatment. Two years later, the only sign Sophia had cancer are the side-effects from the massive doses of chemotherapy given in Sydney.
Researchers at an Australian university believe they have developed a breakthrough showing skin cancer can be stopped by the common cold virus. Skin cancer, or melanoma, is the fifth most common form of cancer. Australia has the highest rate of melanoma in the world, with one out of every two people likely to develop some form of the disease during their lifetime. A team led by Professor Darren Shafren at the University of Newcastle, about 150 kilometers north of Sydney, have established that malignant melanoma cells can be destroyed by infecting them with coxsackievirus, the common cold virus. "We believe this is a significant breakthrough in the development of the treatment of melanoma," Dr Shafren said in a statement released by the university Wednesday. He said the results achieved so far using human cells and in animal studies had been "very exciting". "If we can replicate that success in human trials, the treatment of this often fatal disease could be available within the next few years," he said. According to the university researchers, the projected process begins by injecting the common cold virus into a melanoma. The virus replicates itself and then, according to the projection, begins killing off the melanoma. Within weeks, there is a reduction in the size of the melanoma and it eventually disappears. Dr Shafren noted that the coxsackievirus was not a manufactured drug or a genetically altered virus. Instead, it was a virus that occurred in the community.
Note: Why wasn't this exciting development put on the fast track and lots of money pored in to develop it quickly. Could it be that this cancer treatment would negatively impact the huge profits of the drug companies? For more reliable information on this, click here.
Note: We usually limit ourselves to information from sources known and respected by the public. For this message, we're making an exception. Jeff Rense of rense.com is a radio personality and researcher of major cover-ups with no strong credentials other than a large following of people convinced of the quality of his work. His popular website receives millions of visits a month. Below is vital information everyone should know.
Royal Raymond Rife was a brilliant scientist born in 1888 and died in 1971. He received 14 major awards and honors and was given an honorary Doctorate by the University of Heidelberg for his work. By 1933, he had ... constructed the incredibly complex Universal Microscope, which ... was capable of magnifying objects 30,000 times their normal size. With this incredible microscope, Rife became the first human being to actually see a live virus. In 1934, the University of Southern California appointed a Special Medical Research Committee to bring terminal cancer patients ... to Rife's San Diego Laboratory and clinic for treatment. The team included doctors and pathologists assigned to examine the patients - if still alive - in 90 days. After the 90 days of treatment, the Committee concluded that 86.5% of the patients had been completely cured. On November 20, 1931, forty-four of the nation's most respected medical authorities honored Royal Rife with a banquet. But by 1939, almost all of these distinguished doctors and scientists were denying that they had ever met Rife. The last thing in the world that the pharmaceutical industry wanted was ... a painless therapy that cured ... terminal cancer patients and cost nothing to use but a little electricity. It might give people the idea that they didn't need drugs. Medical journals, supported almost entirely by drug company revenues and controlled by the AMA, refused to publish any paper by anyone on Rife's therapy. Rife technology became public knowledge again in 1986 with the publication of The Cancer Cure That Worked, by Barry Lynes, and other material about Royal Rife and his monumental work.
Note: For excellent video documentaries, including interviews with Royal Rife: http://www.rifevideos.com. For an excellent website focused on Rife's work, click here. For more reliable, verifiable information on health cover-ups, click here.
With a giant, complex microscope invented and constructed in his laboratory workshop, Royal Raymond Rife, San Diego scientist, hopes to unlock mysteries of the bacteria world. Capable of magnifying an object 31,000 times compared with the 1600 to 1700 times of the standard microscope, Rife's instrument had disclosed to his eye minute deadly enemies of the human body which never before, he says, have been seen. Viruses ... have been observed in perfect clarity through his microscope, Rife asserts. One such virus ... has been found in cases of cancer, leading Rife to the belief that intensive future research may show its possible relationship to the cause of this disease. Rife has delved into the mysteries of a wide range of subjects, from ballistics, internal combustion engines and optics to microphotography. But of all of his scientific marvels, the intricately built microscope, culmination of two decades development, seems the greatest. Standing two feet high and weighing 200 pounds, it contains 5682 individual parts. Unlike the standard microscope, the image does not pass through free air in a hollow tube, with the resultant distortion. It is conveyed, instead, zigzag fashion through quartz blocks and prisms along the optical path. For organisms too small to be stained, an ingenious illuminating system is used. This system utilizes Rife's theory that organisms respond to certain wavelengths, a theory he carries to finality by bombarding disease germs with radio waves which are "tuned" to those of the minute man-killers. And the virus he says occurs in cancer has, Rife insists, disintegrated under such radio waves.
Note: As the above link requires payment, you can read the full text of this article free at this link. For over a dozen exciting potential cancer cures reported in the major media, many of which have shown amazing results yet been suppressed or ignored, click here.
Germs that cause cancer have been discovered and with a new high-frequency radio "ray." They have been killed in human patients who then recovered, according to assertions made yesterday at the California State Homeopathic Medical society’s convention. The new progress in combating malignant cancer is said to have been made possible by an ultra microscope that magnifies 31,000 times and by a ray that kills micro-organisms in humans. Both the microscope and the Ray were developed by Royal Raymond Rife of San Diego. Rife was to have announced his discoveries before the British Medical Society, but made the announcement locally because of the war. Dr. Arthur W. Yale of San Diego reported that with the aid of the Rife Ray he has succeeded in curing a number of cases of malignant cancer in which patients had been told they had only a limited time in which to live. The physician [said that] "for 17 years Mr. Rife experimented with vibratory waves of all frequencies, and he has now succeeded in finding a rate that will kill the different invading organisms of the body. Radio waves, which with their harmonics range from 10 meters to 20,000 meters, are projected through a tube filled with helium gas. I have witnessed the disappearance of every malignant growth when the patient has remained under treatment." Dr. Yale then reported case histories of patients treated. Mr. Rife alluded to the fact that the medical profession has not yet accepted his findings. “My work may not be accepted during my lifetime," he said, "but ... I know it ultimately will be recognized.
Note: As the above link requires payment, you can read the full text of this article free at this link. For an abundance of powerful, verifiable information on this amazing man and how his cancer cure was ruthlessly suppressed by the medical establishment, click here.
If the experimental results obtained at the Pasadena Hospital by Dr. Arthur I. Kendall, bacteriologist of Northwestern University, and Dr. Royal R. Rife of San Diego test true, man now has the knowledge and the weapon which will enable him to win the war against disease breeding germs. Having heard about a "wonder microscope," [Dr. Kendall] drove to San Diego and found Royal Raymond Rife and a new kind of microscope. This microscope has six quartz lenses, giving it a magnifying power eight times greater than the high powered-microscopes used by physicists. Dr. Milbank Johnson arranged for Dr. Kendall and Dr. Rife to get together at the Pasadena Hospital where ... the super microscope brought Kendall’s "seeds of life," distinctly within range of human vision. A bacillus or bacterium – a single cell organism – was seen to be made up of "granules." Each kind of granule ... has – under polarized light – a distinctive color of its own, thereby enabling bacteriologists to diagnose germ-diseases by the color of the germs. The bacilli studied are living ones, not corpses killed by stain. So extraordinary are these statements that scientists generally would regard them as visionary, or scientifically impossible, if they were not vouched for by such distinguished authorities. I witnessed a demonstration of the microscope [with] 250 scientists present. The impression prevailed that Dr. Rife ... has developed an instrument that may revolutionize laboratory methods and enable bacteriologists, like Dr. Kendall, to identify the germs that produce about 50 diseases whose cause are unknown, such as colds, influenza, infantile paralysis, measles, mumps, smallpox and ... to find ways and means of immunizing mankind against them.
Scientific discoveries of the greatest magnitude, including a discussion of the world’s most powerful microscope recently perfected after fourteen years effort by Dr. Royal Raymond Rife of San Diego, were described Friday evening to members of the medical profession ... at a dinner given by Dr. Milbank Johnson in honor of Dr. Rife and Dr. Arthur I. Kendall, head of the department of research bacteriology of the medical school of Northwestern, University, Chicago. Through the use of Dr. Rife's powerful microscope ... Dr. Kendall said he could see the typhoid Bacillus in the filterable or formally invisible stage. It is probably the first time the minute filterable organisms ever have been seen. Dr. Rife, who has been working alone in San Diego for more than fourteen years, told of his development of the superpowerful microscope and demonstrated it to the guests. The strongest microscopes now in use magnify between 2001 the 2500 times. Dr. Rife, by and ingenious rearrangement of lenses, applying an entirely new optical principle and by introducing double quartz prisms and powerful illuminating lights, has devised a microscope with a lowest magnification of 5000 diameters and a maximum working magnification of 17,000 diameters. The new microscope, scientists predict, also will prove a development of the first magnitude. Dr. Johnson's guests express themselves as delighted with the visual demonstration and heartily accorded to Dr. Rife and Dr. Kendall a foremost place in the world's rank of scientists.
Note: For a photo of this banquet and full text of the article, click here. For over a dozen exciting potential cancer cures reported in the major media, many of which have shown amazing results yet been suppressed or ignored, click here.
Dr. Walter Bernard Coffey of San Francisco was again asking the State of New York's Department of Social Welfare permission to open a cancer research laboratory and clinic at Huntington, L. I. His cohorts surrounded him. Opposed were Dr. John Augustus Hartwell, president of the New York Academy of Medicine, spokesman for organized Medicine, and his cohorts. The simple question was: Should the State authorize the cancer clinic? But in the train of that simple question came a most extraordinary range of considerations—the nature and cause of cancer; the nature and authenticity of the Coffey-Humber cancer treatment; medical ethics, human nature, public policy, money, fame, and even national politics. Dr. Coffey ... is chief surgeon of Southern Pacific Co. He has 600 doctors working under him. They care for 70,000 railroad men and their families. Dr. John Augustus Hartwell, 61, president of the New York Academy of Medicine ... and most of his associates want Drs. Coffey & Humber and their cancer extract kept away from New York. They fear that the hope of a Coffey-Humber cancer cure will persuade the cancerous to abandon the orthodox treatment of surgery, X-rays and radium. Very quickly after a sufferer gets a Coffey-Humber injection, his pain quiets, and in 71% of the cases disappears. In most of the cases who do not die (Drs. Coffey & Humber will treat only the moribund, cases rejected as hopeless by at least two reputable doctors), the cancer becomes necrotic, ceases to smell, and sloughs off leaving a clean hole. That undeniably happens. Why that happens is debatable.
Note: To read how permission for the innovative cancer clinic was eventually refused, click here. If you want to understand how politics and big money prevented the legitimate study of promising cancer cures back in the 1930s, this article is a highly revealing "must read."
Drs. Coffey & Humber ... last year cautiously announced that they were alleviating hopeless cases of cancer by means of adrenal cortex extract derived from sheep. The Hearst press recognized the kernel of news in this announcement and puffed it so that thousands of cancer victims abandoned the orthodox treatment of surgery, X-rays and radium, rushed for the sure-cure. The two doctors were amazed, but nonetheless swam with the tide of publicity and patients. They opened auxiliary clinics at Los Angeles and Long Beach. They went before a Senate committee to argue for Government aid for cancer research. They gained a patent for their extract. Mrs. Grace Hammond Conners ... gave Drs. Coffey & Humber her $1,000,000 estate, "The Monastery," at Huntington, L. I. Although Dr. Hartwell & friends who last week opposed opening "The Monastery" as a clinic "do not for a minute question the sincerity of Drs. Coffey and Humber in believing they have something of value," the critics "do question the way they have handled their work." The New York men are certain that their San Francisco colleagues have had no training to qualify for research in "the most complex field that exists" in medicine. They do not believe that adrenal cortex extract will cure cancer or that it has value in cancer treatment. They fear that the Californians will experiment on New York humans, hence want them (or at least their methods; excluded, to remain in California where patients are "abundantly available." This was obviously a campaign to ostracize Drs. Coffey & Humber from Manhattan's vicinity. It was conducted ... "by persons who had their own methods, hospitals and funds."
Note: The doctors eventually not only were denied permission to open a cancer clinic for their promising work, they were stripped of the $1 million dollar estate donated to them (worth about $15 million in current U.S. dollars). For the full, fascinating story, click here.
Very cagily did Dr. Edward Sigfrid Sundstroem of the University of California Medical School at Berkeley report last week that experimentally he had cured laboratory-developed cancer in rats by keeping them for three to six weeks in low pressure tanks. The reduced oxygen tension in those tanks simulated atmospheric conditions on tops of mountains four to five miles high. His hesitancy in making the report was due to: 1) ordinary scientific cautiousness; 2) the misinterpretation of the experimental adrenal cortex cancer treatment being tried out by Drs. Walter Bernard Coffey and John Davis Humber in San Francisco. Previous experimenters have retarded growth of cancer cells by low tension oxygen treatment. Dr. Sundstroem declared his were the first "cures" by this means. In it one great danger exists. Minute care must be taken in reducing the atmospheric pressure in the tanks very slowly, else the rats die. Because of this, half of Dr. Sundstroem's test rats died. Of 133 which lived, 83% were definitely freed of their laboratory cancer.
Note: Why wasn't this seriously pursued so that the number who died could be reduced? If 83% of those who survived their cancer were cured, there was clearly great potential there. For a possible answer, click here.
A reported remedy for cancer developed by Dr. W. Blair Bell, of Liverpool, seems, on the basis of the meager information at hand, to be the most promising of all recent " cures" that have been suggested. Dr. Bell's specific is a solution of colloidal lead (a colloid is a gluelike, noncrystalline organic substance that will not pass through a membrane), which appears to have a marked effect on malignant growths like cancer. Dr. Bell has been experimenting with it for 18 years and has recently employed it in 50 cases given up by surgeons as hopeless, checking the cancer in every case, with no recurrence. William Blair Bell is a prominent surgeon and professor of gynecology and obstetrics at the University of Liverpool. He has a high reputation in his specialties, is an authority on the pituitary gland, is author of several standard medical works, including The Sex Complex, has held professorships and won prizes at important hospitals and medical schools in London, Durham, Belfast. That he has not made public his discovery is because he desired to treat many more patients before submitting it to the medical and surgical professions. Dr. Bell's professional standing is in itself strong presumptive evidence of the importance of his treatment, and first-hand details will be eagerly awaited.
Note: For more powerful news articles from the major media on potential cancer cures, click here.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.